[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339323-105":59,"doc-detail-339323-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multiomics-based-molecular-subtyping-based-on-the-commensal-microbiome-predicts-molecular-characteristics-and-the-therapeutic-response-in-breast-cancer","Multiomics-based molecular subtyping based on the commensal microbiome predicts molecular characteristics and the therapeutic response in breast cancer","","The gut microbiota correlates with disease clinical phenotypes, including cancers, yet gut-microbiome–based clinical subtyping remains limited for breast cancer. Using machine learning, the study analyzes gut microbiota from breast, colorectal, and gastric cancer patients to identify shared metabolic pathways and their roles in cancer development. Integrating microbiota-related metabolic pathways, gene expression profiles, and prognosis, it defines a breast cancer subtype termed “challenging BC,” linked to higher mutation burden and a more complex immune milieu. A proposed score index shows significant negative association with prognosis, and poor outcomes relate to TPK1-FOXP3-mediated Hedgehog and TPK1-ITGAE-mediated mTOR signaling. The model is validated via a PDX cohort and predicts response to neoadjuvant therapy, with the score index inversely correlated with treatment efficacy and immune-cell abundance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multiomics-based-molecular-subtyping-based-on-the-commensal-microbiome-predicts-molecular-characteristics-and-the-therapeutic-response-in-breast-cancer/339323/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multiomics-based-molecular-subtyping-based-on-the-commensal-microbiome-predicts-molecular-characteristics-and-the-therapeutic-response-in-breast-cancer/339323.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of the study for breast cancer subtyping?","Question",{"text":112,"@type":113},"To develop a breast cancer subtyping system grounded in gut microbiota-related metabolic pathways and to evaluate how the subtypes relate to molecular characteristics and therapeutic response.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the “challenging BC” subtype and the score index derived?",{"text":117,"@type":113},"The work uses machine learning to analyze shared gut-microbiota metabolic pathways and then combines these pathways with human gene expression profiles and patient prognosis to define a specific subtype and a prognostic score index.",{"name":119,"@type":110,"acceptedAnswer":120},"Which signaling pathways are linked to poor prognosis in high-score “challenging BC” patients?",{"text":121,"@type":113},"Activation of the TPK1-FOXP3-mediated Hedgehog signaling pathway and the TPK1-ITGAE-mediated mTOR signaling pathway is associated with poor prognosis, supported by validation in a patient-derived xenograft (PDX) model.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339323,1790193282,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Qin et al. Molecular Cancer (2024) 23:99 Molecular Cancer  \n[https://doi.org/10.1186/s12943-024-02017-8](https://doi.org/10.1186/s12943-024-02017-8)  \nRESEARCH Open Access  \nMultiomics-based molecular subtyping based  on the commensal microbiome predicts molecular characteristics and the therapeutic response in breast cancer  \nWenxing Qin 1,2*†, Jia Li4†, Na Gao5†, Xiuyan Kong6, Liting Guo3, Yang Chen 1,2, Liang Huang2,8*, Xiaobing Chen7* and Feng Qi3*  \nAbstract  \nThe gut microbiota has been demonstrated to be correlated with the clinical phenotypes of diseases, including cancers. However, there are few studies on clinical subtyping based on the gut microbiota, especially in breast cancer (BC) patients. Here, using machine learning methods, we analysed the gut microbiota of BC, colorectal cancer (CRC), and gastric cancer (GC) patients to identify their shared metabolic pathways and the importance of these pathways in cancer development. Based on the gut microbiota-related metabolic pathways, human gene expression profile and patient prognosis, we established a novel BC subtyping system and identified a subtype called “challenging BC”. Tumours with this subtype have more genetic mutations and a more complex immune environment than those of other subtypes. A score index was proposed for in-depth analysis and showed a significant negative correlation with patient prognosis. Notably, activation of the TPK1-FOXP3-mediated Hedgehog signalling pathway and TPK1-ITGAE-mediated mTOR signalling pathway was linked to poor prognosis in“challenging BC” patients with high scores, as validated in a patient-derived xenograft (PDX) model. Furthermore, our subtyping system and score index are effective predictors of the response to current neoadjuvant therapy regimens, with the score index significantly negatively correlated with both treatment efficacy and the number of immune cells. Therefore, our findings provide valuable insights into predicting molecular characteristics and treatment responses in “challenging BC” patients.  \n†Wenxing Qin, Jia Li and NA Gao contributed equally to this work.  \n*Correspondence:  \nWenxing Qin [qinwenxingqwx@163.com](qinwenxingqwx@163.com)[ ](qinwenxingqwx@163.com)Liang Huang [fdhlyx@163.com](fdhlyx@163.com)  \nXiaobing Chen [zlyychenxb0807@zzu.edu.cn](zlyychenxb0807@zzu.edu.cn)[ ](zlyychenxb0807@zzu.edu.cn)Feng Qi  \n[qf12486@rjh.com.cn](qf12486@rjh.com.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nQin et al. Molecular Cancer (2024) 23:99  \nIntroduction  \nThe gut microbiota plays crucial roles in the occurrence, development, and treatment of diseases, including cancers [1–7]. For example, Fusobacterium nucleatum participates in the regulation of colorectal cancer (CRC) development [8–10], and the abundances of Enterobacteriaceae an","cbCaigrR7SjLAG4G","https://ap.wps.com/l/cbCaigrR7SjLAG4G","pdf",13024341,17,"English","# Abstract\n# Introduction","[{\"question\":\"What is the purpose of the study for breast cancer subtyping?\",\"answer\":\"To develop a breast cancer subtyping system grounded in gut microbiota-related metabolic pathways and to evaluate how the subtypes relate to molecular characteristics and therapeutic response.\"},{\"question\":\"How were the “challenging BC” subtype and the score index derived?\",\"answer\":\"The work uses machine learning to analyze shared gut-microbiota metabolic pathways and then combines these pathways with human gene expression profiles and patient prognosis to define a specific subtype and a prognostic score index.\"},{\"question\":\"Which signaling pathways are linked to poor prognosis in high-score “challenging BC” patients?\",\"answer\":\"Activation of the TPK1-FOXP3-mediated Hedgehog signaling pathway and the TPK1-ITGAE-mediated mTOR signaling pathway is associated with poor prognosis, supported by validation in a patient-derived xenograft (PDX) model.\"}]","Multiomics-based molecular subtyping based on the commensal microbiome predicts molecular characteristics and the therapeutic response in breast cancer | PDF",1790029538,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e56bd167f29b0e00019b7908de3f49b8.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50a36d82b755b9493fde5b93d8006031.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e64bf6d51862c34261f8f9bd124e8ba.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/58ab7a803311224071760f6b7dd5aee3.webp",980,1306]